Oral administration of polyphenolic compounds from cognac decreases ADP-induced platelet aggregation and reduces chronotropic effect of isoprenaline in rats

Physiological Research

Volumn 57, Issue 4, 2008, Pages 517-524

  Carusio, N ^a,b   Wangensteen, R ^a   Filippelli, A ^b   Andriantsitohaina, R ^a  

^a Universite d'Angers   (France)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cognac; Isoprenaline; Nitric oxide; Platelet aggregation; Polyphenols

Indexed keywords

ADENOSINE DIPHOSPHATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COLLAGEN; FLAVONOID; ISOPRENALINE; NITRIC OXIDE; PHENOL DERIVATIVE; POLYPHENOLS;

ALCOHOLIC BEVERAGE; ANIMAL; ARTICLE; CELL ADHESION; DRUG ANTAGONISM; DRUG EFFECT; ELECTRON SPIN RESONANCE; HEART; HEART MUSCLE; HEART RATE; MALE; METABOLISM; PHYSIOLOGY; RAT; THORACIC AORTA; THROMBOCYTE AGGREGATION; WISTAR RAT;

ADENOSINE DIPHOSPHATE; ADRENERGIC BETA-AGONISTS; ALCOHOLIC BEVERAGES; ANIMALS; AORTA, THORACIC; CELL ADHESION; COLLAGEN; ELECTRON SPIN RESONANCE SPECTROSCOPY; FLAVONOIDS; HEART; HEART RATE; ISOPROTERENOL; MALE; MYOCARDIUM; NITRIC OXIDE; PHENOLS; PLATELET AGGREGATION; RATS; RATS, WISTAR;

EID: 50449088703     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ALENCAR JL, LOBYSHEVA I, CHALUPSKY K, GEFFARD M, NEPVEU F, STOCLET JC, MULLER B: S-Nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries. J Pharmacol Exp Ther 307: 152-159, 2003.
2. ANDRIAMBELOSON E, KLESCHYOV AL, MULLER B, BERETZ A, STOCLET JC, ANDRIANTSITOHAINA R: Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol 120: 1053-1058, 1997.
3. ANDRIAMBELOSON E, MAGNIER C, HAAN-ARCHIPOFF G, LOBSTEIN A, ANTON R, BERETZ A, STOCLET JC, ANDRIANTSITOHAINA R: Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr 128: 2324-2333, 1998.
4. BERETZ A, CAZENAVE JP, ANTON R: Inhibition of aggregation and secretion of human-platelets by quercetin and other flavonoids - structure activity relationships. Agents Actions 12: 382-387, 1982.
5. CARANDO S, TEISSEDRE P-L, FERRIERE M, DESCOMPS B, CABANIS J-C: Athérosclérose: Physiopathologie. Boissons alcoolisées et cardiopathies ischémiques, in: Masson, Cahier de nutrition et de diététique. Société de nutrition et de dietetìque de langue française (SNDLF). 1998, pp. 182-187.
6. CAZENAVE JP, HEMMENDINGER S, BERETZ A, SUTTER-BAY A, LAUNAY J: L'agrégation plaquettaire: outil d'investigation clinique et d'étude pharmacologique. Méthodologie. Ann Biol Clin 41: 167-179, 1983.
7. CURIN Y, ANDRIANTSITOHAINA R: Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol Rep 57 (Suppl): 97-107, 2005.
8. DA PORTO C, CALLIGARIS S, CELOTTI E, NICOLI MC: Antiradical properties of commercial cognacs assessed by the DPPH(.) test. J Agric Food Chem 48: 4241-4245, 2000.
9. DIEBOLT M, BUCHER B, ANDRIANTSITOHAINA R: Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 38: 159-165, 2001.
10. GOLDBERG DM, HOFFMAN B, YANG J, SOLEAS GJ: Phenolic constituents, furans, and total antioxidant status of distilled spirits. J Agric Food Chem 47: 3978-3985, 1999.
11. GYORGY K, MULLER B, VEGH A, KLESCHYOV AL, STOCLET JC: Triggering role of nitric oxide in the delayed protective effect of monophosphoryl lipid A in rat heart. Br J Pharmacol 127: 1892-1898, 1999.
12. HUBBARD GP, WOLFFRAM S, LOVEGROVE JA, GIBBINS JM: The role of polyphenolic compounds in the diet as inhibitors of platelet function. Proc Nutr Soc 62: 469-78, 2003.
13. JOSEPHY PD, LORD HL, SNIECKUS VA: Inhibition of benzo[a]pyrene dihydrodiol epoxide mutagenicity by synthetic analogues of ellagic acid. Mutat Res 242 143-149, 1990.
14. KLESCHYOV AL, MOLLNAU H, OELZE M, MEINERTZ T, HUANG Y, HARRISON DG, MUNZEL T: Spin trapping of vascular nitric oxide using colloid Fe (II)-diethyldithiocarbamate. Biochem Biophys Res Commun 275: 672-677, 2000.
15. LIU W, LIANG NC: Inhibitory effect of disodium quercetin-7, 4-disulfate on aggregation of pig platelets induced by thrombin and its mechanism. Acta Pharmacol Sin 21: 737-741, 2000.
16. MAJID S., KHANDUJA KL, GANDHI RK, KAPUR S, SHARMA RR: Influence of ellagic acid on antioxidant defense system and lipid peroxidation in mice. Biochem Pharmacol 42: 1441-1445, 1991.
17. PARK JW: Interventional cardiology versus minimally invasive cardiac surgery. Eur J Cardiothorac Surg 16 (Suppl 2): S117-S118, 1999.
18. PECHÁŇOVÁ O, BERNÁTOVÁ I, BABÁL P, MARTINEZ MC, KYSELÁ S, ŠTVRTINA S, ANDRIANTSITOHAINA R: Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 22: 1551-1559, 2004.
19. PEREZ-VIZCAINO F, DUARTE J, ANDRIANTSITOHAINA R: Endothelial function and cardiovascular disease: Effects of quercetin and wine polyphenols Free Radic Res 40: 1054-1065, 2006.
20. RALAY RANAIVO H, DIEBOLT M, SCHOTT C, ANDRIANTSITOHAINA R: Polyphenolic compounds from Cognac induce vasorelaxation in vitro and decrease post-ischaemic cardiac infarction after an oral administration. Fundam Clin Pharmacol 18: 331-338, 2004.
21. RENAUD S, DE LORGERIL M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526, 1992.
22. RIMM EB, GIOVANNUCCI EL, WILLETT WC, COLDITZ GA, ASCHERIO A, ROSNER B, STAMPFER MJ: Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338: 464-468, 1991.
23. ROTONDO S, DE GAETANO G: Protection from cardiovascular disease by wine and its derived products. Epidemiological evidence and biological mechanisms. World Rev Nutr Diet 87: 90-113, 2000.
24. UMAR A, GUERIN V, RENARD M, BOISSEAU M, GARREAU C, BEGAUD B, MOLIMARD M, MOORE N: Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo. Thromb Res 110: 135-140, 2003.
25. UMAR A, DEPONT F, JACQUET A, LIGNOT S, SEGUR MC, BOISSEAU M, BEGAUD B, MOORE N: Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trial. Thromb Res 115: 31-37, 2005.
26. YOU KM, JONG HG, KIM HP: Inhibition of cyclooxygenase/lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants. Arch Pharm Res 22: 18-24, 1999.
27. VITA JA: Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81: 292S-297S, 2005.